News > WHO warns about counterfeit diabetes drugs in circulation worldwide
WHO warns about counterfeit diabetes drugs in circulation worldwide
Mid-day | 21/06/2024 01:15 PM | Click to read full article
Counterfeit diabetes drugs have been in circulation since 2022, the World Health Organisation warned. The drug concerns Ozempic, a medicine containing the active ingredient semaglutide, which is also approved in the EU for the treatment of Type 2 diabetes. The counterfeit version looks identical to the real medicine. Because the product also suppresses the appetite, it is increasingly being prescribed for weight loss.
